Answers are grounded in this paper and cite their sources.
Although prevalent among viral hepatitis patients, MDD did not affect disease progression or survival in either HBV or HCV cohorts. TCA use was associated with poor decompensated cirrhosis-free survival. Therefore, its use should be further studied among viral hepatitis patients.
No takes yet. Share an insight, caveat, or question.
Shaheen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: